The many roles of histone deacetylases in development and physiology: implications for disease and therapy (original) (raw)

• Cheung, W. L., Briggs, S. D. & Allis, C. D. Acetylation and chromosomal functions. Curr. Opin. Cell Biol. 12, 326–333 (2000).
  Article CAS PubMed Google Scholar
• Grunstein, M. Histone acetylation in chromatin structure and transcription. Nature 389, 349–352 (1997).
  Article CAS PubMed Google Scholar
• Clayton, A. L., Hazzalin, C. A. & Mahadevan, L. C. Enhanced histone acetylation and transcription: a dynamic perspective. Mol. Cell 23, 289–296 (2006).
  Article CAS PubMed Google Scholar
• Shahbazian, M. D. & Grunstein, M. Functions of site-specific histone acetylation and deacetylation. Annu. Rev. Biochem. 76, 75–100 (2007).
  Article CAS PubMed Google Scholar
• Ruthenburg, A. J., Li, H., Patel, D. J. & Allis, C. D. Multivalent engagement of chromatin modifications by linked binding modules. Nature Rev. Mol. Cell Biol. 8, 983–994 (2007).
  Article CAS Google Scholar
• Kouzarides, T. Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 19, 1176–1179 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Rundlett, S. E. et al. HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription. Proc. Natl Acad. Sci. USA 93, 14503–14508 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, A., Kurdistani, S. K. & Grunstein, M. Requirement of Hos2 histone deacetylase for gene activity in yeast. Science 298, 1412–1414 (2002).
  Article CAS PubMed Google Scholar
• De Nadal, E. et al. The MAPK Hog1 recruits Rpd3 histone deacetylase to activate osmoresponsive genes. Nature 427, 370–374 (2004).
  Article CAS PubMed Google Scholar
• Nusinzon, I. & Horvath, C. M. Histone deacetylases as transcriptional activators? Role reversal in inducible gene regulation. Sci. STKE 296, re11 (2005).
  Google Scholar
• Glaser, K. B. et al. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Mol. Cancer Ther. 2, 151–163 (2003).
  CAS PubMed Google Scholar
• Montgomery, R. L. et al. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev. 21, 1790–1802 (2007). Reports the first conditional knockout of a class I HDAC.
  Article CAS PubMed PubMed Central Google Scholar
• Lahm, A. et al. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc. Natl Acad. Sci. USA 104, 17335–17340 (2007). Describes the mechanism for the loss of enzymatic activity in class IIa HDACs.
  Article CAS PubMed PubMed Central Google Scholar
• Schwer, B. & Verdin, E. Conserved metabolic regulatory functions of sirtuins. Cell. Metab. 7, 104–112 (2008).
  Article CAS PubMed Google Scholar
• Longo, V. D. & Kennedy, B. K. Sirtuins in aging and age-related disease. Cell 126, 257–268 (2006).
  Article CAS PubMed Google Scholar
• Guarente, L. Sirtuins as potential targets for metabolic syndrome. Nature 444, 868–874 (2006).
  Article CAS PubMed Google Scholar
• Bordone, L. & Guarente, L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nature Rev. Mol. Cell Biol. 6, 298–305 (2005).
  Article CAS Google Scholar
• Taunton, J., Hassig, C. A. & Schreiber, S. L. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272, 408–411 (1996). A seminal paper describing the cloning of the first mammalian HDAC.
  Article CAS PubMed Google Scholar
• Yang, X. J. & Seto, E. The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nature Rev. Mol. Cell Biol. 9, 206–218 (2008). An elegant review about the classical HDAC family.
  Article CAS Google Scholar
• Kurdistani, S. K. & Grunstein, M. Histone acetylation and deacetylation in yeast. Nature Rev. Mol. Cell Biol. 4, 276–284 (2003).
  Article CAS Google Scholar
• Yang, X. J. & Seto, E. Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression. Curr. Opin. Genet. Dev. 13, 143–153 (2003).
  Article CAS PubMed Google Scholar
• Vega, R. B. et al. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol. Cell Biol. 24, 8374–8385 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• McKinsey, T. A., Zhang, C. L., Lu, J. & Olson, E. N. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408, 106–111 (2000). The first study to show that class IIa HDACs are signal-responsive modulators of gene expression.
  Article CAS PubMed PubMed Central Google Scholar
• Lu, J., McKinsey, T. A., Nicol, R. L. & Olson, E. N. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc. Natl Acad. Sci. USA 97, 4070–4075 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Passier, R. et al. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Invest. 105, 1395–1406 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Lu, J., McKinsey, T. A., Zhang, C. L. & Olson, E. N. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell 6, 233–244 (2000).
  Article CAS PubMed Google Scholar
• Youn, H. D., Grozinger, C. M. & Liu, J. O. Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4. J. Biol. Chem. 275, 22563–22567 (2000).
  Article CAS PubMed Google Scholar
• Wang, A. H. et al. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol. Cell Biol. 19, 7816–7827 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Miska, E. A. et al. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18, 5099–5107 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Sparrow, D. B. et al. MEF-2 function is modified by a novel co-repressor, MITR. EMBO J. 18, 5085–5098 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, C. L. et al. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110, 479–488 (2002). Describes the first knockout of a class IIa HDAC.
  Article CAS PubMed PubMed Central Google Scholar
• Chang, S. et al. Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol. Cell Biol. 24, 8467–8476 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Vega, R. B. et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119, 555–566 (2004).
  Article CAS PubMed Google Scholar
• Chang, S. et al. Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 126, 321–334 (2006). Reports the first conditional class IIa HDAC knockout.
  Article CAS PubMed Google Scholar
• Fischle, W. et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol. Cell 9, 45–57 (2002). The first definitive report showing that class IIa HDAC enzymatic activity is due to the copurification of class I HDACs.
  Article CAS PubMed Google Scholar
• Jones, P. et al. Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases. Bioorg. Med. Chem. Lett. 18, 1814–1819 (2008).
  Article CAS PubMed Google Scholar
• Zhang, C. L., McKinsey, T. A., Lu, J. R. & Olson, E. N. Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor. J. Biol. Chem. 276, 35–39 (2001).
  Article CAS PubMed Google Scholar
• Zhang, C. L., McKinsey, T. A. & Olson, E. N. Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation. Mol. Cell Biol. 22, 7302–7312 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, C. L., McKinsey, T. A. & Olson, E. N. The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis. Proc. Natl Acad. Sci. USA 98, 7354–7359 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Dressel, U. et al. A dynamic role for HDAC7 in MEF2-mediated muscle differentiation. J. Biol. Chem. 276, 17007–17013 (2001).
  Article CAS PubMed Google Scholar
• Bottomley, M. J. et al. Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain. J. Biol. Chem. 283, 26694–26704 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Schuetz, A. et al. Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity. J. Biol. Chem. 283, 11355–11363 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, Y. et al. Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Mol. Cell Biol. 28, 1688–1701 (2008). Describes the first knockout of a class IIb HDAC.
  Article CAS PubMed PubMed Central Google Scholar
• Fischer, D. D. et al. Isolation and characterization of a novel class II histone deacetylase, HDAC10. J. Biol. Chem. 277, 6656–6666 (2002).
  Article CAS PubMed Google Scholar
• Guardiola, A. R. & Yao, T. P. Molecular cloning and characterization of a novel histone deacetylase HDAC10. J. Biol. Chem. 277, 3350–3356 (2002).
  Article CAS PubMed Google Scholar
• Tang, X. et al. Acetylation-dependent signal transduction for type I interferon receptor. Cell 131, 93–105 (2007).
  Article CAS PubMed Google Scholar
• Zhang, X. et al. HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol. Cell 27, 197–213 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Kovacs, J. J. et al. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol. Cell 18, 601–607 (2005).
  Article CAS PubMed Google Scholar
• Matsuyama, A. et al. In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J. 21, 6820–6831 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Hubbert, C. et al. HDAC6 is a microtubule-associated deacetylase. Nature 417, 455–458 (2002).
  Article CAS PubMed Google Scholar
• Gao, L., Cueto, M. A., Asselbergs, F. & Atadja, P. Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J. Biol. Chem. 277, 25748–25755 (2002).
  Article CAS PubMed Google Scholar
• Liu, H., Hu, Q., Kaufman, A., D'Ercole, A. J. & Ye, P. Developmental expression of histone deacetylase 11 in the murine brain. J. Neurosci. Res. 86, 537–543 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Lagger, G. et al. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 21, 2672–2681 (2002). Reports the first knockout of a class I HDAC
  Article CAS PubMed PubMed Central Google Scholar
• Zupkovitz, G. et al. Negative and positive regulation of gene expression by mouse histone deacetylase 1. Mol. Cell Biol. 26, 7913–7928 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Yamaguchi, M. et al. Histone deacetylase 1 regulates retinal neurogenesis in zebrafish by suppressing Wnt and Notch signaling pathways. Development 132, 3027–3043 (2005).
  Article CAS PubMed Google Scholar
• Cunliffe, V. T. Histone deacetylase 1 is required to repress Notch target gene expression during zebrafish neurogenesis and to maintain the production of motoneurones in response to hedgehog signalling. Development 131, 2983–2995 (2004).
  Article CAS PubMed Google Scholar
• Cunliffe, V. T. & Casaccia-Bonnefil, P. Histone deacetylase 1 is essential for oligodendrocyte specification in the zebrafish CNS. Mech. Dev. 123, 24–30 (2006).
  Article CAS PubMed Google Scholar
• Pillai, R., Coverdale, L. E., Dubey, G. & Martin, C. C. Histone deacetylase 1 (HDAC-1) required for the normal formation of craniofacial cartilage and pectoral fins of the zebrafish. Dev. Dyn. 231, 647–654 (2004).
  Article CAS PubMed Google Scholar
• Nambiar, R. M., Ignatius, M. S. & Henion, P. D. Zebrafish colgate/hdac1 functions in the non-canonical Wnt pathway during axial extension and in Wnt-independent branchiomotor neuron migration. Mech. Dev. 124, 682–698 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Farooq, M. et al. Histone deacetylase 3 (hdac3) is specifically required for liver development in zebrafish. Dev. Biol. 317, 336–353 (2008).
  Article CAS PubMed Google Scholar
• Trivedi, C. M. et al. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nature Med. 13, 324–331 (2007).
  Article CAS PubMed Google Scholar
• Voss, A. K., Thomas, T. & Gruss, P. Efficiency assessment of the gene trap approach. Dev. Dyn. 212, 171–180 (1998).
  Article CAS PubMed Google Scholar
• Chen, F. et al. Hop is an unusual homeobox gene that modulates cardiac development. Cell 110, 713–723 (2002).
  Article CAS PubMed Google Scholar
• Kook, H. et al. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J. Clin. Invest. 112, 863–871 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Shin, C. H. et al. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 110, 725–735 (2002).
  Article CAS PubMed Google Scholar
• Kuwahara, K. et al. The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes. Mol. Cell Biol. 21, 2085–2097 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Nakagawa, Y. et al. Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes. J. Mol. Cell Cardiol. 41, 1010–1022 (2006).
  Article CAS PubMed Google Scholar
• Kuwahara, K. et al. NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. EMBO J. 22, 6310–6321 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Montgomery, R. L. et al. Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice. J. Clin. Invest. 118, 3588–3597 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Bhaskara, S. et al. Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. Mol. Cell 30, 61–72 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Knutson, S. K. et al. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J. 27, 1017–1028 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Trivedi, C. M., Lu, M. M., Wang, Q. & Epstein, J. A. Transgenic over-expression of Hdac3 in the heart produces increased postnatal cardiac myocyte proliferation but does not induce hypertrophy. J. Biol. Chem. 283, 26484–26489 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Karsenty, G. The complexities of skeletal biology. Nature 423, 316–318 (2003).
  Article CAS PubMed Google Scholar
• Cohen, M. M. Jr. The new bone biology: pathologic, molecular, and clinical correlates. Am. J. Med. Genet. A 140, 2646–2706 (2006).
  Article PubMed CAS Google Scholar
• Arnold, M. A. et al. MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev. Cell 12, 377–89 (2007).
  Article CAS PubMed Google Scholar
• Kronenberg, H. M. PTHrP and skeletal development. Ann. NY Acad. Sci. 1068, 1–13 (2006).
  Article CAS PubMed Google Scholar
• Song, K. et al. The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases. Cell 125, 453–466 (2006).
  Article CAS PubMed Google Scholar
• McKinsey, T. A. & Olson, E. N. Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J. Clin. Invest. 115, 538–546 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Backs, J. & Olson, E. N. Control of cardiac growth by histone acetylation/deacetylation. Circ. Res. 98, 15–24 (2006).
  Article CAS PubMed Google Scholar
• Hill, J. A. & Olson, E. N. Cardiac plasticity. N. Engl. J. Med. 358, 1370–1380 (2008).
  Article CAS PubMed Google Scholar
• Kim, Y. et al. The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J. Clin. Invest. 118, 124–32 (2008).
  Article CAS PubMed Google Scholar
• Backs, J., Song, K., Bezprozvannaya, S., Chang, S. & Olson, E. N. CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J. Clin. Invest. 116, 1853–1864 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Bassel-Duby, R. & Olson, E. N. Signaling pathways in skeletal muscle remodeling. Annu. Rev. Biochem. 75,19-37 (2006).
• Kim, M. S. et al. Protein kinase D1 stimulates MEF2 activity in skeletal muscle and enhances muscle performance. Mol. Cell Biol. 28, 3600–3609 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Potthoff, M. J. et al. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J. Clin. Invest. 117, 2459–2467 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Mejat, A. et al. Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression. Nature Neurosci. 8, 313–321 (2005).
  Article CAS PubMed Google Scholar
• Haberland, M. et al. Regulation of HDAC9 gene expression by MEF2 establishes a negative-feedback loop in the transcriptional circuitry of muscle differentiation. Mol. Cell Biol. 27, 518–525 (2007).
  Article CAS PubMed Google Scholar
• Lindsey, M. L., Mann, D. L., Entman, M. L. & Spinale, F. G. Extracellular matrix remodeling following myocardial injury. Ann. Med. 35, 316–326 (2003).
  Article CAS PubMed Google Scholar
• Jiang, Y., Goldberg, I. D. & Shi, Y. E. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21, 2245–2252 (2002).
  Article CAS PubMed Google Scholar
• Lee, A. Y. et al. Quantitative analysis of histone deacetylase-1 selective histone modifications by differential mass spectrometry. J. Proteome Res. 31 Oct 2008 (doi:10.1021/pr800510p).
  Article CAS PubMed Google Scholar
• Jones, P. et al. 2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors. Bioorg. Med. Chem. Lett. 18, 3456–3461 (2008).
  Article CAS PubMed Google Scholar
• Bolden, J. E., Peart, M. J. & Johnstone, R. W. Anticancer activities of histone deacetylase inhibitors. Nature Rev. Drug Discov. 5, 769–784 (2006).
  Article CAS Google Scholar
• Duvic, M. et al. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood 109, 31–39 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Xu, W. S., Parmigiani, R. B. & Marks, P. A. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26, 5541–5552 (2007).
  Article CAS PubMed Google Scholar
• Marks, P. A. Discovery and development of SAHA as an anticancer agent. Oncogene 26, 1351–1356 (2007).
  Article CAS PubMed Google Scholar
• Marks, P. A. & Breslow, R. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nature Biotechnol. 25, 84–90 (2007).
  Article CAS Google Scholar
• Karagiannis, T. C. & El-Osta, A. Modulation of cellular radiation responses by histone deacetylase inhibitors. Oncogene 25, 3885–3893 (2006).
  Article CAS PubMed Google Scholar
• Zimmermann, S. et al. Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice. Cancer Res. 67, 9047–9054 (2007).
  Article CAS PubMed Google Scholar
• Lehrman, G. et al. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet 366, 549–555 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M. & Tsai, L. H. Recovery of learning and memory is associated with chromatin remodelling. Nature 447, 178–182 (2007).
  Article CAS PubMed Google Scholar
• Reddy, P. et al. Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J. Clin. Invest. 118, 2562–2573 (2008).
  CAS PubMed PubMed Central Google Scholar
• Kong, Y. et al. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113, 2579–2588 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Granger, A. et al. Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J. 22, 3549–3560 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, B. et al. HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats. Brain Res. 1226, 181–191 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Williams, J. A. et al. Valproic acid prevents brain injury in a canine model of hypothermic circulatory arrest: a promising new approach to neuroprotection during cardiac surgery. Ann. Thorac. Surg. 81, 2235–2241; discussion 2241–2242 (2006).
  Article PubMed Google Scholar
• Almeida, A. M. et al. Targeted therapy for inherited GPI deficiency. N. Engl. J. Med. 356, 1641–1647 (2007). Describes the 'cure' of an inherited genetic disorder using an HDAC inhibitor.
  Article CAS PubMed Google Scholar
• Kim, S. C. et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 23, 607–618 (2006). An elegant screen for the 'acetylome'.
  Article CAS PubMed Google Scholar
• Mann, B. S., Johnson, J. R., Cohen, M. H., Justice, R. & Pazdur, R. FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist 12, 1247–1252 (2007). This study highlights the first US Food and Drug Administration (FDA) approval of an HDAC inhibitor.
  Article CAS PubMed Google Scholar
• Olsen, E. A. et al. Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma. J. Clin. Oncol. 25, 3109–3115 (2007).
  Article CAS PubMed Google Scholar
• Luhrs, H. et al. Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand. J. Gastroenterol. 37, 458–466 (2002).
  Article CAS PubMed Google Scholar
• Atweh, G. F. et al. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood 93, 1790–1797 (1999).
  CAS PubMed Google Scholar
• Chung, Y. L., Lee, M. Y., Wang, A. J. & Yao, L. F. A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. Mol. Ther. 8, 707–717 (2003).
  Article CAS PubMed Google Scholar
• Choi, J. H. et al. Trichostatin A attenuates airway inflammation in mouse asthma model. Clin. Exp. Allergy 35, 89–96 (2005).
  Article CAS PubMed Google Scholar
• Camelo, S. et al. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J. Neuroimmunol. 164, 10–21 (2005).
  Article CAS PubMed Google Scholar
• Glauben, R. et al. Histone hyperacetylation is associated with amelioration of experimental colitis in mice. J. Immunol. 176, 5015–5022 (2006).
  Article CAS PubMed Google Scholar
• Antos, C. L. et al. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J. Biol. Chem. 278, 28930–28937 (2003).
  Article CAS PubMed Google Scholar
• Reddy, P. et al. Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect. Proc. Natl Acad. Sci. USA 101, 3921–3926 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Leoni, F. et al. The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo. Mol. Med. 11, 1–15 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Minetti, G. C. et al. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nature Med. 12, 1147–1150 (2006).
  Article CAS PubMed Google Scholar
• Mishra, N., Reilly, C. M., Brown, D. R., Ruiz, P. & Gilkeson, G. S. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J. Clin. Invest. 111, 539–552 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Avila, A. M. et al. Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. J. Clin. Invest. 117, 659–671 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Sailhamer, E. A. et al. Acetylation: a novel method for modulation of the immune response following trauma/hemorrhage and inflammatory second hit in animals and humans. Surgery 144, 204–216 (2008).
  Article PubMed Google Scholar